140 related articles for article (PubMed ID: 17525718)
21. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
23. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
24. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
[TBL] [Abstract][Full Text] [Related]
26. Emerging therapies for inv(16) AML.
Surapally S; Tenen DG; Pulikkan JA
Blood; 2021 May; 137(19):2579-2584. PubMed ID: 33821975
[TBL] [Abstract][Full Text] [Related]
27. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
28. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
[TBL] [Abstract][Full Text] [Related]
30. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
31. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
[TBL] [Abstract][Full Text] [Related]
32. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
[TBL] [Abstract][Full Text] [Related]
33. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
[TBL] [Abstract][Full Text] [Related]
34. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
35. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
Serrano E; Carnicer MJ; Lasa A; Orantes V; Pena J; Brunet S; Aventín A; Sierra J; Nomdedéu JF
Leuk Res; 2008 Jun; 32(6):944-53. PubMed ID: 18206229
[TBL] [Abstract][Full Text] [Related]
37. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia.
Kogan SC; Lagasse E; Atwater S; Bae SC; Weissman I; Ito Y; Bishop JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11863-8. PubMed ID: 9751756
[TBL] [Abstract][Full Text] [Related]
38. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
[TBL] [Abstract][Full Text] [Related]
39. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
40. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
